Biotech
Fortrea Grows with New Deal
Fortrea is expanding its business by buying a part of Worldwide Clinical Trials for $45 million.
Fortrea wants to help get new medicines to people faster. The company just announced a big step forward. It will buy a part of another company, Worldwide Clinical Trials.
This deal costs Fortrea $45 million. It helps Fortrea do more early-stage drug testing. Early-stage testing means checking new drugs on a small group of people. This step is very important for new medicines.
Adding this part of Worldwide Clinical Trials makes Fortrea's work stronger. It means more help for companies making new drugs. This move can speed up how new treatments reach patients. Faster research helps everyone looking for better health.
Source: FierceBiotech
#Biotech#Acquisition
More from Biotech
